Oncology

What We’re Reading: Public Health Emergency in Puerto Rico; Depression Rates and Anxiety Screening; Cancer Death Rates Decrease

September 21st 2022, 2:45pm

HHS declared a public health emergency in Puerto Rico due to Hurricane Fiona; nearly 1 in 10 Americans suffered from depression in 2020, and a task force recommended doctors screen all adults aged younger than 65 for anxiety; advances in cancer research have led to reduced cancer death rates.

Part I: The Promise of Telehealth – A Cautionary Tale

September 15th 2022, 9:50pm

The rise of telehealth during COVID-19, its limitations, and its uncertain future.

FDA Approves Darolutamide Combo for Metastatic Hormone-Sensitive Prostate Cancer

August 9th 2022, 3:57pm

Darolutamide, sold as Nubeqa, is an androgen receptor inhibitor, which works to limit prostate cell growth by preventing the binding of hormones, or androgens, to proteins known as androgen receptors.

Dr Elaine Goodman Discusses Changes in Health Care Technologies, Patient Engagement

July 28th 2022, 4:45pm

Elaine Goodman, MD, MBA, clinical lead for population health management at Mass General Brigham, explains how patient access and engagement with health technologies, and the ways these technologies are developed, has evolved.

Knowledge of Health Insurance, Financial Literacy Fail to Prevent Financial Hardship Among Patients With Cancer

July 27th 2022, 7:38pm

A team of investigators from across the United States investigated a potential connection between patients’ health insurance literacy and their reported financial hardship.

ASCO Spotlight With David R. Penberthy, MD, MBA: Knowledge Gained at ASCO Can Transform Cancer Care

July 22nd 2022, 1:17pm

ASCO Spotlight With Ravi B. Parikh, MD, MPP: Can Nudges Increase the Number of Serious Illness Conversations in Community Oncology?

July 22nd 2022, 12:14pm

Ravi B. Parikh, MD, MPP, assistant professor, Department of Medical Ethics and Health Policy and Medicine, Perelman School of Medicine, University of Pennsylvania, presented long-term results from an experiment with an algorithm designed to prompt oncologists to have serious illness conversations.

Dr Debra Patt Discusses the Paradigm Shift of Treating HER2-Low Breast Cancer

July 19th 2022, 1:35pm

Previously, patients with low expression of HER2 were categorized as HER2-negative but adding the HER2-low classification creates new opportunities for patients with advanced breast cancer, explained Debra Patt, MD, PhD, MBA, executive vice president of Texas Oncology.

Dr Ben Robbins Talks About GV's Presence in Health Care

July 11th 2022, 7:07pm

Benjamin Robbins, MD, MBA, venture partner at GV, explains how the venture capital firm decides to invest in health care companies.

Provider and Patient Insights Into the Cancer Care Journey

July 11th 2022, 1:00pm

A survey was conducted to determine opportunities to aid primary care providers and patients in the difficult journey of an oncology patient.